Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:1332-1333
Published online before print February 19, 2009, doi: 10.1161/STROKEAHA.108.528976
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/4/1332    most recent
STROKEAHA.108.528976v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnston, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnston, K. C.
Related Collections
Right arrow Health policy and outcome research
Right arrow CT and MRI
Right arrow Acute Cerebral Infarction

(Stroke. 2009;40:1332.)
© 2009 American Heart Association, Inc.


Original Contributions

Clinical and Imaging Data at 5 Days as a Surrogate for 90-Day Outcome in Ischemic Stroke

Karen C. Johnston, MD, MSc; Kevin M. Barrett, MD; Yong Hong Ding, MD; Douglas P. Wagner, PhD{dagger} for the ASAP Investigators

From the Departments of Neurology (K.C.J., K.M.B.) and Public Health Sciences (K.C.J., D.P.W.), University of Virginia, Charlottesville; and the Department of Radiology (Y.H.D.), Mayo Clinic, Rochester, NY.

Correspondence to Karen C. Johnston, MD, MSc, University of Virginia Health System, Department of Neurology, #800394, Charlottesville, VA 22908-0394. E-mail kj4v{at}virginia.edu

Background and Purpose— A simple, easily measured surrogate outcome measure for use in early treatment trials for acute ischemic stroke therapies would be highly valued. We hypothesized that day-5 NIH stroke scale score (NIHSS) and day-5 diffusion weighted imaging (DWI) volume would predict clinical outcome better than either alone and could be considered as a possible surrogate outcome in early phase acute stroke trials.

Methods— The prospective Acute Stroke Accurate Prediction (ASAP) trial included a prespecified subgroup evaluated for early outcome. Logistic regression analysis was used to assess the prediction of modified Rankin (mRankin) of 0 or 1.

Results— A total of 204 subjects completed the substudy, and 116 (57%) had excellent outcome at 3 months. The area under the ROC curve (AUC) for day-5 NIHSS predicting 3-month excellent outcome was 0.84; for DWI volume predicting outcome was 0.76, and for the multivariable model combining both was 0.84.

Conclusions— The results of the early outcome substudy of the ASAP trial suggest that early stroke severity and infarct volume measures are predictive of 3-month excellent outcome. In our data set the DWI volume does not add clinically relevant information in predicting 3-month outcome. Validation of these results is required.


Key Words: cerebral ischemia • prognosis • stroke outcome • models • statistical • surrogate




This article has been cited by other articles:


Home page
NeurologyHome page
A. E. Baird
Improving stroke prognosis
Neurology, October 6, 2009; 73(14): 1084 - 1085.
[Full Text] [PDF]